Comprehensive MS-based screening and identification of pharmaceutical transformation products formed during enzymatic conversion
In this study, transformation products (TPs) of diclofenac, mefenamic acid, and sotalol derived from peroxidase- and laccase-catalyzed transformations were studied with different mass spectrometry (MS)-based workflows. A straightforward pre-screening of enzymatic degradation rate was performed using a robotic nano-ESI source coupled to single quadrupole MS. Accurate mass data and information on molecular hydrophobicity were obtained from a serial coupling of reversed phase liquid chromatography (RPLC) with hydrophilic interaction liquid chromatography (HILIC) to a time-of-flight-mass spectrometer (ToF-MS). These parameters were combined with fragmentation information from product ion scan operated in enhanced mode (EPI) with precursor selection in Q3 and data from multiple reaction monitoring (MRM) modes using a hybrid triple quadrupole-linear ion trap-mass spectrometer (QqQ/LIT-MS). “Suspect” MRM modes did not provide a significant sensitivity improvement compared to EPI experiments. The complementarity of the data from different MS-based workflows allowed for an increase of identification confidence. Overall, this study demonstrated that dimerization, hydroxylation, and dehydration reactions were the predominant mechanisms found for diclofenac and mefenamic acid during enzyme-catalyzed transformation, whereas a degradation product was observed for the peroxidase-catalyzed conversion of sotalol. Results can contribute to understand enzymatic mechanisms and provide a basis for assessing risks and benefits of enzyme-based remediation.
KeywordsMass spectrometer HPLC Pharmaceuticals Oxidative enzymes Transformation products
This study was partially supported by the Bavarian State Ministry of the Environment and Consumer Protection.
Compliance with ethical standards
All authors are aware of and accept responsibility for this manuscript.
Conflict of interest
The authors declare that they have no competing interests.
- 2.Jelić A, Gros M, Petrović M, Ginebreda A, Barceló D. Occurrence and Elimination of pharmaceuticals during conventional wastewater treatment. In: Guasch H, Ginebreda A, Geiszinger A, editors. Emerging and priority pollutants in Rivers: bringing science into river management plans. Berlin: Springer Berlin Heidelberg; 2012. p. 1–23.Google Scholar
- 3.Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett. 2002;131(1–2):5–17.Google Scholar
- 5.Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—a review. Sci Total Environ. 2012;429:123–55.Google Scholar
- 8.Luo Y, Guo W, Ngo HH, Nghiem LD, Hai FI, Zhang J, et al. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci Total Environ. 2014;473:619–41.Google Scholar
- 9.Hollender J, Zimmermann SG, Koepke S, Krauss M, McArdell CS, Ort C, et al. Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ Sci Technol. 2009;43(20):7862–9. https://doi.org/10.1021/es9014629.Google Scholar
- 15.Lu J, Huang Q. Removal of acetaminophen using enzyme-mediated oxidative coupling processes: I. Reaction rates and pathways. Environ Sci Technol. 2009;43:7062–7.Google Scholar
- 16.Hata T, Kawai S, Okamura H, Nishida T. Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation. Biodegradation. 2010;21(5):681–9.Google Scholar
- 18.Kobakhidze A, Elisashvili V, Corvini PF, Cvancarova M. Biotransformation of ritalinic acid by laccase in the presence of mediator TEMPO. New Biotechnol. 2017. https://doi.org/10.1016/j.nbt.2017.08.008.
- 23.Kosjek T, Heath E, Petrović M, Barceló D. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. TrAC Trends Anal Chem. 2007;26(11):1076–85.Google Scholar
- 25.Drewes JE, Letzel T. Chemicals of emerging concern and their transformation products in the aqueous environment. assessing transformation products of chemicals by non-target and suspect screening− strategies and workflows volume 1. ACS Publications; 2016. p. 3–9.Google Scholar
- 26.Letzel T, Bayer A, Schulz W, Heermann A, Lucke T, Greco G, et al. LC-MS screening techniques for wastewater analysis and analytical data handling strategies: sartans and their transformation products as an example. Chemosphere. 2015;137:198–206. https://doi.org/10.1016/j.chemosphere.2015.06.083. Google Scholar
- 29.Greco G, Grosse S, Letzel T. Serial coupling of reversed-phase and zwitterionic hydrophilic interaction LC/MS for the analysis of polar and nonpolar phenols in wine. J Sep Sci. 2013;36(8):1379–88.Google Scholar
- 30.Grosse S, Letzel T. User Manual for STOFF-IDENT Database 2016;4.2:1–33.Google Scholar
- 31.Rajab M, Greco G, Heim C, Helmreich B, Letzel T. Serial coupling of RP and zwitterionic hydrophilic interaction LC-MS: suspects screening of diclofenac transformation products by oxidation with a boron-doped diamond electrode. J Sep Sci. 2013;36(18):3011–8. https://doi.org/10.1002/jssc.201300562. Google Scholar
- 36.Lucas FW, Mascaro LH, Fill TP, Rodrigues-Filho E, Franco-Junior E, Homem-de-Mello P, et al. Diclofenac on boron-doped diamond electrode: from electroanalytical determination to prediction of the electrooxidation mechanism with HPLC-ESI/HRMS and computational simulations. Langmuir. 2014;30(19):5645–54. https://doi.org/10.1021/la4044123. Google Scholar
- 38.Venkataraman H, Den Braver MW, Vermeulen NP, Commandeur JN. Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases. Chem Res Toxicol. 2014;27(12):2071–81.Google Scholar
- 39.Khalit WNAW, Tay KS. Aqueous chlorination of mefenamic acid: kinetics, transformation by-products and ecotoxicity assessment. Environ Sci Processes Impacts. 2016;18(5):555–61.Google Scholar
- 40.Jeon JR, Baldrian P, Murugesan K, Chang YS. Laccase-catalysed oxidations of naturally occurring phenols: from in vivo biosynthetic pathways to green synthetic applications. Microb Biotechnol. 2012;5(3):318–32.Google Scholar